---
title: "Vaccinex to delist Common Stock from Nasdaq; suspended since Dec 18, 2024; aiming a differentiated approach in treating neurodegenerative diseases."
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/231050516.md"
description: "On March 07, 2025, in Rochester, New York, Vaccinex, Inc. (OTC: VCNX) revealed its plan to remove its common stock from the Nasdaq. The clinical-stage biotech firm focuses on tackling neurodegenerative diseases by targeting astrogliosis and neuroinflammation via SEMA4D inhibition. The stock's Nasdaq trading halt commenced on December 18, 2024."
datetime: "2025-03-07T22:32:49.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/231050516.md)
  - [en](https://longbridge.com/en/news/231050516.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/231050516.md)
generator: "portal-rs"
---

# Vaccinex to delist Common Stock from Nasdaq; suspended since Dec 18, 2024; aiming a differentiated approach in treating neurodegenerative diseases.

On March 07, 2025, in Rochester, New York, Vaccinex, Inc. (OTC: VCNX) revealed its plan to remove its common stock from the Nasdaq. The clinical-stage biotech firm focuses on tackling neurodegenerative diseases by targeting astrogliosis and neuroinflammation via SEMA4D inhibition. The stock's Nasdaq trading halt commenced on December 18, 2024.

### Related Stocks

- [VCNX.US](https://longbridge.com/en/quote/VCNX.US.md)

## Related News & Research

- [How Shelf Registration Will Impact Celldex Therapeutics (CLDX) Stock Investors](https://longbridge.com/en/news/305560069.md)
- [GE HealthCare Technologies (GEHC) Tests Its Brain Imaging Narrative As Undervalued View Holds](https://longbridge.com/en/news/305561290.md)
- [Missed Viasat's 88% Gain? Here's What Investors Got Right](https://longbridge.com/en/news/305561187.md)
- [Independence Realty Trust (IRT) Faces Activist Pressure, Is It Still 19% Undervalued?](https://longbridge.com/en/news/305560374.md)
- [What to expect from Aramark’s Q3 earnings](https://longbridge.com/en/news/305560829.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**